KCT0003527
Recruiting
未知
The magnetic resonance imaging assessment of non-alcoholic fatty liver disease and the evaluation of prognostic factors in patients undergoing bariatric surgery
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Gachon University Gil Medical Center
- Enrollment
- 75
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects who understood this clinical study and provided written informed consent to join the study by his or her own decision
- •\- Aged 19 or more years or less than 60 years
- •\- Subjects who have body mass index \=30 kg per square meter and metabolic disease (at least one the following: impaired fasting glucose, hemoglobin A1c 5\.7% or more, diabetes, nonalcoholic fatty liver disease, hypertension, hypertriglyceridemia, or metabolic syndrome).
- •\- Absence of specific congenital diseases or absence of other chronic diseases and their symptom or signs requiring specific treatment, except for metabolic diseases
Exclusion Criteria
- •\- Aged less than 19 years or 60 years or more
- •\- Pregnant or lactating women
- •\- Body weight \>159 kg
- •\- Drug abusers
- •\- Alcohol consumption (alcohol intake \>20 g/day for women; \>30 g/day for men) during \= 3months in the past 5 years
- •\- Psychiatric patients on medical care or medication or subjects with bulimia
- •\- Those with AST or ALT level higher than 5 times the upper limit of normal
- •\- Those with platelet count \< 60,000 per microliter or with prothrombin time longer than 4 seconds or more than the upper limit of normal (14 seconds)
- •\- Contraindications to MRI examination
- •\- Other specific liver diseases except for NAFLD
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron OverloadMedDRA version: 19.0Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2016-000246-62-Outside-EU/EEAovartis53
Not yet recruiting
Not Applicable
Evaluating the use of Magnetic Resonance Imaging and Contrast Enhanced Mammography after MagTrace® usebreast cancermammacarcinoma10006291NL-OMON51366Zuyderland Medisch Centrum40
Recruiting
Not Applicable
ltrasound and magnetic resonance imaging to assess muscle contractile performance in FSHD.disease of Landouzy-Dejerinefacioscapulohumeral dystrophy1002839610028302NL-OMON56047Radboud Universitair Medisch Centrum100
Not yet recruiting
Not Applicable
Magnetic Resonance Imaging (MRI) and radiological study of Rheumatoid Arthritis treated with Adalimumab and non-biological agents to assess the impact of disease control on MRI manifestations and joint structure preservation.Rheumatoid ArthritisMusculoskeletal - Other muscular and skeletal disordersACTRN12612000903886Emeritus Research180
Active, not recruiting
Not Applicable
A Phase 2a Magnetic Resonance Imaging Study of the Safety and Efficacy of MLN1202 in patients with Multiple Sclerosis - Not appilcableThe purpose of this study is to investigate the safety, PK parameters, PD responses, and clinical responses of multiple dose administration of MLN1202 in patients with relapsing remitting multiple sclerosis (RRMS).EUCTR2004-002567-24-CZMillennium Pharmaceuticals, Inc.160